We have examined the reconstitution of ␥␦ T cell repertoire diversity after human allogeneic hematopoietic cell transplantation using a polymerase chain reaction (PCR)-based complementarity-determining region (CDR) 3 size spectratyping and DNA sequencing. The CDR3 complexity in the variable region of the T cell receptor (TCR)-␦ chain was different amongst the individuals studied. Furthermore, CDR3 size distribution patterns of allogeneic hematopoietic cell transplant recipients were almost completely recovered by a few months after transplantation. In some patients, clonal predominance of the TCRDV1+ T cells became evident during the period after transplantation. In one particular donor/recipient pair, clonal predominance of TCRDV1+ T cells was already present in blood lymphocytes of the donor, and was also observed in the recipient after transplantation. Using this donor/recipient pair, we have questioned whether ␥␦ T cell regeneration occurs via the peripheral expansion of mature T cells in the graft. In the donor lymphocytes, two expanding ␥␦ T cell clones, which were demonstrated by CDR3 sequences of the TCR-␦ chain, were recognized. These two clones were identified in the T cells from the recipient post transplant, but not before transplantation. One of the two clones was still detectable 1. years after the transplant procedure. These results strongly suggest that peripheral expansion of mature T cells in the graft is the principal pathway of ␥␦ T cell regeneration after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplantation (2000) 26, 177-185. Keywords: T cell receptor; ␦-chain; diversity; transplantation High-dose chemoradiotherapy depletes T cells in blood and marrow transplant recipients and adequate T cell regeneration is essential for successful transplantation. The repertoire of T cells requires to be sufficiently diverse in order to recognize a wide range of microorganism-derived antigens. ␣␤ T cells are almost exclusively thymus-dependent
for their development during ontogeny. In contrast, ␥␦ T cells can be generated in extrathymic tissues. Recently, it has been demonstrated that rearrangement of TCRDV genes occurs initially in the liver and gut during ontogeny, 1, 2 although there are also a few reports describing the selection of ␥␦ T cells in the thymus. 3, 4 There are three potential pathways of T cell regeneration after hematopoietic transplantation: thymus-dependent and thymus-independent extrathymic pathways of T-cell differentiation and peripheral expansion of mature T cells in the graft. In adults, thymic tissues are mostly atrophic, which suggests that extrathymic differentiation of T cell progenitors and/or peripheral expansion of mature T cells are the principal mechanisms of T cell regeneration in adult marrow transplant recipients. Mackall et al 5, 6 reported that when the numbers of T cells in the graft were limited, skewing of the TCRBV repertoire was observed in mice. This finding has recently been confirmed in humans. 7 Patients receiving highly purified hematopoietic progenitor grafts showed decreased diversity of V␤ TCR expression associated with a decline in the absolute number of circulating T cells. We and others have found that TCR␣␤+ T cell repertoire diversity, which has been analyzed by CDR3 size distribution analysis of the TCR-␤ chain, of bone marrow recipients correlates with their immune status. 8, 9 However, the nature of human ␥␦ T cell repertoire diversity regeneration after hematopoietic cell transplantation has not been fully elucidated. Although the number of germline TCR-␥ and -␦ genes available for recombination are more limited than TCR-␣ and -␤ genes, the TCR ␦ chain can utilize two in-frame D rearrangements, resulting in the generation of potentially enormous diversity within a CDR3 region. 10 In this study, we have addressed how the reconstitution of ␥␦ T cell repertoire occurs after human allogeneic hematopoietic cell transplantation and also asked whether ␥␦ T cell regeneration occurs as a result of peripheral expansion of mature T cells in the graft.
Materials and methods

Patients
Twenty-three patients who received an allogeneic blood or marrow graft, were included in this study. Informed consent was obtained from the patients and donors before blood samples were taken. All the patients were conditioned with myeloablative chemoradiotherapy, mostly consisting of fractionated total body irradiation (12 Gy in six fractions) and cyclophosphamide (60 mg/kg/day for 2 days), followed by infusion of allogeneic marrow (n = 20; age, 16 to 49 years) or blood stem cell grafts (n = 3; age, 16 to 45 years) from HLA-matched donors. All the patients received cyclosporin A and short-term methotrexate for prophylaxis of acute graft-versus-host disease (GVHD). 11 Engraftment was achieved in all patients, and was confirmed by recovery of hematopoiesis and the presence of donor-derived sex chromosome or mismatched antigens on red cells. Clinical grading of acute GVHD was determined according to the criteria reported by Glucksberg et al. 12 Patients were monitored for cytomegalovirus (CMV) infection by weekly CMV antigenemia assays 13 from the time when the granulocyte count reached 500/l until day 100 after transplantation. Patients who were positive for CMV antigenemia assay received prophylactic ganciclovir (5 mg/kg/day, 3 days a week) from the time when the granulocyte count was greater than 1000/l. 14 
Flow cytometry
Peripheral blood mononuclear cells (PBMC) were isolated by the Ficoll/Conray gradient centrifugation method from heparinized blood. PBMC were stained with FITC-or PEconjugated monoclonal antibodies and were analyzed using a flow cytometer (Cytron Absolute, Ortho Diagnostics, Tokyo, Japan). Monoclonal antibodies used in this study were as follows: anti-CD3 (SK7, IgG1; Becton Dickinson, San Jose, CA, USA); anti-CD4 (MT310, IgG1; Dako, Carpinteria, CA, USA); anti-CD8 (DK25, IgG1; Dako); anti-TCR pan ␥␦ (11F2, IgG1; Becton Dickinson): control mouse IgG (X40, IgG1; Dako).
CDR3 size spectratyping of TCRDV
The procedure of CDR3 size analysis for TCR ␦-chains has been described elsewhere. 15 Total RNA was extracted from PBMC using RNeasy Total RNA Kit (Qiagen, Hilden, Germany) and was used for first-strand cDNA synthesis with an oligo-dT primer (First-Strand cDNA Synthesis Kit, Amersham Pharmacia Biotech, Uppsala, Sweden). Aliquots of the cDNA were amplified with either a V␦1-or a V␦2-specific oligonucleotide (designated VD1 and VD2, respectively) and the C␦ primer (CD1). PCR amplification was performed for 40 cycles in 20 l reaction mixture containing 0.2 m of each primer and 0.5 units Taq polymerase (TaKaRa, Osaka, Japan). Conditions for the PCR on the thermal cycler were as follows: denaturation at 94°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C (Table 1) . This patient has recently been described elsewhere. 46 AML = acute myelogenous leukemia; CR1 = first complete remission; ALL = acute lymphoblastic leukemia; CML = chronic myelogenous leukemia; CP1 = first chronic phase; MDS = myelodysplastic syndrome; RA = refractory anemia; RAEB = refractory anemia with excess of blasts; BM = bone marrow; PBSC = peripheral blood stem cell; IP = interstitial pneumonia; CMV = cytomegalovirus; HSV = herpes simplex virus; HHV-6 = human herpes virus-6; NE = not evaluable. for 1.5 min. Following the 40 cycles of PCR, an additional extension at 72°C for 15 min was performed. Aliquots (4 l) of the unlabeled V␦-C␦ PCR products were subjected to one cycle of elongation (runoff) reaction with a FAM-labeled C␦ primer (FAM-CD3). The runoff Bone Marrow Transplantation reaction conditions were as follows: denaturation at 94°C for 2 min, annealing at 55°C for 1 min, and extension at 72°C for 15 min. Oligonucleotide sequences of the VD1, VD2, CD1 and FAM-CD3 primers were as follows: VD1, GTGGTCGCTATTCTGTCAACT; VD2, GCTCCAT-GAAAGGAGAAGCGA; CD1, AACAGCATTCGTAGCC CAAGCAC; FAM-CD3, FAM-GTTTATGGCAGCTC TTTGAAGGT. 16 The labeled PCR products were loaded on acrylamide sequencing gels for determination of size and fluorescence intensity on an automated DNA sequencer (ABI 377, Perkin-Elmer Applied Biosystems, Foster, CA, USA), followed by analysis using GeneScan software (Perkin-Elmer Applied Biosystems).
Sequencing of CDR3 region in the TCR-␦ chain
PCR products of the TCR-␦ chain were cloned into the PCR2.1 TA cloning vector (Invitrogen, Carlsbad, CA, USA) and were sequenced using a Big-Dye Terminator Cycle Sequencing Kit (Perkin-Elmer Applied Biosystems). Sequence analysis was performed using an Applied Biosystems 377A automated DNA sequencer.
Results
␥␦ T-lymphocyte subset after allogeneic marrow transplantation
Numerous reports have described reconstitution of lymphocyte subsets after bone marrow transplantation. Lower numbers of circulating CD4 + T lymphocytes are the consistent finding during the initial 3 to 6 months after transplantation, 17, 18 which has been confirmed in our series of marrow transplant recipients. Post-transplant profiles of lymphocytes subsets are shown in Figure 1 . The percentage of ␥␦ T cells in blood lymphocytes was quite stable before and after transplant in this study. There was no statistical difference in the number of ␥␦ T cells between the patients with and without acute GVHD (data not shown), although there have been a few reports describing that the presence of acute GVHD was associated with ␥␦ T lymphocytosis. 19 It has been also reported that CMV reactivation is associated with the expansion of ␥␦ T cells in the peripheral blood of renal allograft recipients. 20, 21 In our patients receiving allogeneic marrow grafts, there was no obvious increase in the number of ␥␦ T cells, although most of the patients were positive for CMV serology. This discrepant result may be explained by the different patient cohort (renal vs marrow grafting).
Reconstitution of CDR3 complexity in the TCR-␦ chain during the early phase of transplant
We have examined the recovery of CDR3 complexity of TCR-␦ chain in eleven patients after transplantation. We have employed two sets of primers (V␦1/C␦1 and V␦2/C␦1) in order to determine the CDR3 size distribution pattern of the TCR-␦ chain. Patient characteristics whose blood lymphocytes were analyzed for the CDR3 size distribution pattern are shown in Table 1 . CDR3 size distribution patterns of TCR-␦ chain were distinct among the blood and marrow donors. While some donors showed a typical Gaussian distribution pattern (Figure 2 , TCRDV2 for UPN43), which means a polyclonal T cell population, others showed a clonal predominance (Figure 2, TCRDV1 for UPN42 ). During the first 3 months after transplantation, recipients are susceptible to various opportunistic microorganisms. We have recently found that immunocompromised hosts with virus-associated interstitial pneumonia (IP) had defective TCR-V␤ diversity. 9 Therefore, initially the question of whether any difference in the TCR-␦ chain diversity would be detected between the immunocompetent and immunocompromised hosts was investigated. As shown in Figures 2 and 3 , CDR3 complexity of the TCR-␦ chain was almost completely recovered by the initial 2 months after allogeneic marrow transplant in both patient groups. In addition, early reconstitution of ␥␦ T cell repertoire seems to be donor-dependent, since CDR3 complexity of TCRDV1+ and TCRDV2+ T cells is similar between the donor and recipient. This is also the case with the recipients receiving an allogeneic blood stem cell graft (Figure 4 ).
Stable CDR3 complexity in long-term survivors after transplantation
Next, we addressed the question of whether the regenerated ␥␦ T cell diversity would be stable long term. CDR3 complexity of TCRDV2+ T cells was quite stable over time in not only immunocompetent but also immunocompromised Bone Marrow Transplantation recipients ( Figure 5 ). Interestingly, clonal predominance of TCRDV1+ T cells became evident over time after transplantation in both patients. However, this clonal predominance of TCRDV1+ T cells was not evident in a recipient of an allogeneic blood stem cell graft (Figure 6 ), suggesting that the number of TCRDV1+ T cells in the graft may be related to the clonal expansion of TCRDV1+ T cells after transplantation.
Role of peripheral expansion of mature T cell population in regeneration of ␥␦ T cell repertoire diversity after allogeneic hematopoietic cell transplantation
We have identified one particular patient (UPN42) whose bone marrow donor showed clonal predominance in the CDR3 region of TCRDV1. Using this particular donor/recipient pair, we addressed the question of whether ␥␦ T cells would be generated from mature T cells in the graft by analyzing the structure of CDR3 region of the TCR-␦ chain. Table 2 shows the nucleotide sequences of the DV1-D-J junctional region in the donor and recipient. Oligoclonality of the TCR-␦ repertoire in the donor lymphocytes was confirmed by the presence of repetitive appearance of the same CDR3 sequence (ND1ND2ND3N; TAFLWGIQ and WAPFPGGP). These DNA sequences were not found in the recipient's circulating lymphocytes prior to transplantation. The same CDR3 sequences were identified in the lymphocytes from the recipient 2 months Longitudinal CDR3 size distribution analysis in a patient receiving an allogeneic blood stem cell graft. Table 2 Deduced amino acid sequences of CDR3 region of TCR-␦ chain in blood T lymphocytes from the donor and recipient before and after transplantation Table 2) . One of these clones (WAPFPGGP) was present over the 1. years after transplantation. These results strongly suggest that ␥␦ T cell regeneration occurs via the peripheral T cell expansion pathway.
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Discussion
We have firstly demonstrated that post-transplant ␥␦ T cell repertoire diversity is donor-dependent and can be regenerated during the first 2 months after transplantation in adult patients. Although the function of ␥␦ T cells is not quite clear yet, there is accumulating evidence of their importance in response to intracellular microorganisms such as Mycobacterium tuberculosis or Listeria monocytogenes [22] [23] [24] and anti-leukemia effects. 25 In addition, it is now clear that ␥␦ T cells can recognize nonpeptide antigens [26] [27] [28] in a manner which is entirely different from how ␣␤ T cells recognize their processed antigens in the context of major histocompatibility complex (MHC)/peptide. 29, 30 Our results showed that recovery of CDR3 complexity of the TCR-␦ chain appeared to be almost complete during the initial 2 months after transplantation, suggesting that marrow transplant recipients are immunocompetent for the microorganisms with antigens that ␥␦ T cells can recognize. In fact, although marrow transplant recipients are prone to bacterial, viral and fungal infections, the incidence of Mycobacterium tuberculosis or Listeria monocytogenes infection is lower than other infections. [31] [32] [33] [34] In agreement with other investigators, we have shown that the regeneration profiles of the ␣␤ T cell repertoire diversity after allogeneic blood and marrow transplantation are different Bone Marrow Transplantation among patients depending upon their immunocompetence. 8, 9 These results and the clinical observations described above suggest that the host immunocompetence is dependent on the recovery of ␣␤ T cell repertoire, although the role for ␥␦ T cells in post-transplant immune responses to pathogens including CMV 20, 21 has yet to be determined.
Secondly, we have demonstrated that donor-derived ␥␦ T cell clones were identified in circulating T cells from the marrow recipient over 1. years after transplantation. Potential thymus-independent pathways of T cell regeneration include extrathymic differentiation of T cell progenitors and peripheral expansion of the mature T cell population in the graft. Animal studies have shown that extrathymic differentiation of T cell progenitors gives rise to unusual T cell populations such as TCR␥␦+, 35 intermediate TCR␣␤+ 36 or TCR␣␤+CD4−CD8− T cells. 37 The extensive proliferation of mature T cells termed peripheral expansion has also been described [38] [39] [40] and this process can generate substantial numbers of CD4+ TCR␣␤+ and CD8+ TCR␣␤+ T cell populations. In humans, the thymus undergoes atrophy during puberty, suggesting that extrathymic differentiation of T cell progenitors and/or peripheral expansion of mature T cells are the principal mechanisms of T cell regeneration in adult marrow transplant recipients. Our results support the hypothesis that the generation of human ␥␦ T cell repertoire diversity after blood and marrow transplantation occurs via the mechanism of peripheral expansion of mature T cells present in the graft. However, the possibility that thymic and/or extrathymic differentiation of T cell progenitors may occur after hematopoietic cell transplantation in adults can not be precluded, since certain TCRDV1-CDR3 sequences were only found in the blood from the recipient after transplantation but not before transplant or in donor lymphocytes. This issue must be precisely and carefully addressed in the future.
Over the past several years, the maintenance of the naive and memory mature-T cell pools has attracted considerable attention from immunologists. 41 For TCR␣␤+ T cells, the continuous TCR ligation to MHC molecules is required for survival in vivo. 42, 43 It has been reported in mice that there is a difference in the requirement of cognate ligand (antigen) for survival between naive and memory T cells. 44, 45 Memory TCR␣␤+ T cells can divide in an antigen-independent fashion. Moreover, the phenotype of the peripheral T cells reconstituted early after marrow transplantation has been reported to be memory-type TCR␣␤+CD8+ T cells. 5, 6 In our study, ␥␦ T cell regeneration appears to be prompt in adult blood and marrow transplant recipients, suggesting that the requirement for the maintenance of TCR␥␦+ T cell pool may be similar to that of TCR␣␤+CD8+ memory T cells. To address this issue, further investigation is required.
